CASI Pharma (CASI) Tops Q1 EPS by 3c

CASI Pharma (NASDAQ: CASI) reported Q1 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $9 million versus the consensus estimate of $9.23 million.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Hyperscale Data acquires 48.5 acres to expand Michigan campus
• Argus starts SpaceX at Hold, sees record IPO as a multi-year re-rating challenge